Appraisals

Quote


















My RD even said they did skew the rankings since the company did not meet forecast. I believe 45% used to get 4 or higher now it's about 30%. Which is an easy way to stop reps from moving levels and getting an additional 5-7% raise.
 












anonymous said:
My RD even said they did skew the rankings since the company did not meet forecast. I believe 45% used to get 4 or higher now it's about 30%. Which is an easy way to stop reps from moving levels and getting an additional 5-7% raise.
Click to expand...
My 2018 was better than 2017. I got a lower appraisal level for the 2018 year than the 2017 year. I was already skeptical, but that was my solid proof that they are not transparent. Then 2019 Sh*t show was just icing on the cake.

I, unlike many others who have stayed, do not drink the koolaid. I am a double dipper and have no trouble sleeping at night after the “loyalty” Supernus has shown me.
 






anonymous said:
This place is a joke. Management, products, and upper management. This place is what’s wrong with Pharma. 812 will not launch. 810 is dead.
Click to expand...

actually, this place is exactly like Pharma. Other companies have been doing this for a decade or longer.

We rode the good times, now it’s time to either suck it up or find the next company in growth mode.
 






anonymous said:
actually, this place is exactly like Pharma. Other companies have been doing this for a decade or longer.

We rode the good times, now it’s time to either suck it up or find the next company in growth mode.
Click to expand...


You are absolutely correct we are past growth mode and EVERY pharma company out there experiences this. What makes Supernus a unique assho"e is that they haven't changed their bonus plan. EVERY pharma company out there once they are passed growth stages change their bonus plan. Aimovig changed their bonus structure after the first year for this very reason. So far half the nation, HALF!!!! is negative for Q1 and on pace to make less than $1k in bonus for the quarter.

So if you are going to tout that we are passed growth mode at least acknowledge our bonus plan is not industry standard. Get a grip.
 






anonymous said:
You are absolutely correct we are past growth mode and EVERY pharma company out there experiences this. What makes Supernus a unique assho"e is that they haven't changed their bonus plan. EVERY pharma company out there once they are passed growth stages change their bonus plan. Aimovig changed their bonus structure after the first year for this very reason. So far half the nation, HALF!!!! is negative for Q1 and on pace to make less than $1k in bonus for the quarter.

So if you are going to tout that we are passed growth mode at least acknowledge our bonus plan is not industry standard. Get a grip.
Click to expand...

Not backing them up but didn’t they change the bonus plan to payout for negative share growth?
 
























anonymous said:
We might all have to, given the current state. But since I have more experience there, this time I’d be your boss
Click to expand...

the company is healthy and the financial status is excellent. Supernus continues to grow and make money. The stock will continue to climb and all is good. We are a healthy organization with 900+ million in cash. We just have to continue in growing Trokendi XR and Oxtellar XR for the next year. 812 will launch in Q1 and undoubtedly will be successful
 






anonymous said:
the company is healthy and the financial status is excellent. Supernus continues to grow and make money. The stock will continue to climb and all is good. We are a healthy organization with 900+ million in cash. We just have to continue in growing Trokendi XR and Oxtellar XR for the next year. 812 will launch in Q1 and undoubtedly will be successful
Click to expand...
The company is healthy but you all must suffer while we pretend we have our schitt together. Here are some peanuts for your inconvenience.
 


















anonymous said:
So is corporate going to address the coverage issues and the new generics that are coming out?
Click to expand...

This ^^^^^. Also, how does corporate plan to compensate reps equitably when you have some states with 25% commercial coverage and NO Medicaid......but then you have other states with double or triple that in commercial coverage WITH MEDICAID COVERAGE. PREFERRED.

How is that going to be addressed?????? Are we all still going to be graded on the same criteria despite differing circumstances???
 
























Top Bottom
Back
Quote